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Objective: To determine if behavioral graded activity (BGA) results in better long-term effectiveness (5
years after inclusion) than usual exercise therapy (UC; usual care) in patients with osteoarthritis (OA) of
the hip or knee.
Method: Long-term follow-up study of a single blind cluster randomized trial comparing BGA and UC.
One hundred and forty-nine patients out of the 200 included were followed until 60 months’ follow-up.
Primary outcome measures were pain, physical function, and patient global assessment. Furthermore,
patient-oriented physical function, physical performance, health care utilization and the number of joint
replacement surgeries were assessed. Assessments took place at 3, 9, 15 and 60 months’ follow-up. Data
were analyzed according to intent-to-treat principle.
Results: Both treatments showed beneﬁcial within-groups effects in the long-term. In patients with knee
OA no differences between treatments were found on the short-, mid-long and long-term. In patients
with hip OA signiﬁcant differences in favor of BGA were found at 3 months’ (pain and physical perfor-
mance) and 9 months’ follow-up (pain, physical function, patients global assessment and patient-
oriented physical function). Furthermore, UC resulted in patients with hip OA in more joint replacement
surgeries compared to BGA (hazard ratio [HR], 2.87; 95% conﬁdence interval [CI], 1.1; 7.3).
Conclusion: No differences between treatment groups were found in the long-term on the primary
outcome measures. Although more research is needed to conﬁrm the study ﬁndings, the results indicate
that BGA reduces the risk for joint replacement surgeries compared to UC in patients with hip OA, which
probably can be explained by better outcome in favor of BGA in the short- and mid-long-term.
Randomized controlled trial Trial Registration: ClinicalTrials.gov, identiﬁer: NCT00522106.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) of the hip or knee is a common chronic and
degenerative musculoskeletal disorder with a high prevalence
increasing with age1. OA causes impairments in body functions and
physical functioning, which often leads to moderate to severe
limitations in participation and a decreased quality of life2e4. In
several guidelines for the medical management of OA of the hip orartijn F. Pisters, Netherlands
Box 1568, 3500 BN, Utrecht,
9729.
s Research Society International. Pknee the use of pharmacologic agents (e.g., simple analgesic or anti-
inﬂammatory drugs) and non-pharmacologic modalities (e.g.,
patient education and exercise therapy) are recommended5e7. In
advanced disease, partial or total replacement of joints often
becomes unavoidable. In earlier stages of disease patients are often
referred for physical therapy treatment to reduce impairments and
improve overall physical function, so that individuals can meet the
demands of daily living as long as possible.
Several studies have demonstrated beneﬁcial short-term effect
of exercise therapy on pain, physical functioning and patients’ self
perceived effect8e10. So far, only a few studies investigated the long-
term effectiveness of exercise therapy and the studies that do exist
used relatively short follow-up periods, varying from 6 to 15ublished by Elsevier Ltd. All rights reserved.
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seem to decline over time after discharge and ﬁnally disappear in
the long-term11. Low exercise adherence rates after discharge are
seen as one of the main reasons to explain poor long-term effec-
tiveness of exercise therapy12,13. Furthermore, stimulation of
a physically active lifestyle seems important, because a lack of
regular physical activity is an important risk factor for functional
decline in patients with OA14. In most existing studies investigating
the effectiveness of exercise therapy, the exercise programs con-
sisted primarily of muscle strengthening exercises. To stimulate
exercise adherence and a more physically active lifestyle post-
treatment, it is suggested that exercise programs should become
more functional and task-oriented, including additional booster
sessions and strategies to improve exercise behavior and self-
regulation skills15.
Veenhof et al. developed and evaluated an exercise program
integrating operant behavioral principles, self-regulation principles
and additional booster sessions called the ‘behavioral graded
activity’ (BGA) program16. The BGA treatment is an individually
tailored exercise program in which patients’ most problematic
physical activities are gradually increased in a time-contingent way.
Furthermore, the intervention includes individually tailored exer-
cises to improve impairments limiting the performance of these
activities. The ultimate goal is integration of these exercises and
activities in patients’ daily living, so that patients get a more
physically active lifestyle. In additional booster sessions patients
are supported and stimulated to sustain their physically active
lifestyle and integrate exercises and activities in their daily life.
Earlier research has shown no signiﬁcant differences between BGA
and usual exercise therapy according to the Dutch guideline (usual
care; UC) on pain, self-reported physical function and patient global
assessment (PGA). However, signiﬁcant differences in favor of BGA
were found on physical performance, patient-oriented physical
functioning, and patients’ physical activity level16. Furthermore,
patients treated with BGA were signiﬁcantly more adherent to
advised exercises compared to patients treated with usual exercise
therapy, namely 75% vs 44% in the short-term and 59% vs 34% in the
mid-long-term17. Because of the better results in patients treated
with BGA on exercise adherence and patients’ physical activity
level, it is expected that BGA results in better long-term effective-
ness than UC. Therefore, the objective of the current study was to
compare the long-term effectiveness (5 years after inclusion)
between UC and BGA in patients with OA on the hip and/or knee.
Methods
This article reports a follow-up study (5 years after inclusion) of
a single blind cluster randomized trial comparing BGA and UC in
200 patients with hip or knee OA16,18. The study was approved by
the medical ethics committee of the VU University Medical Center,
Amsterdam and performed in compliance with the Declaration of
Helsinki. Full details of the trial protocol (in Dutch) are available on
request from the authors.
Setting and participants
Eighty-seven physiotherapists (working in 72 practices) from
the region of Utrecht were willing to participate in the study.
Patients with OA of the hip or knee were recruited (November
2001eMay 2003) by participating physiotherapist and by articles
about the study in local newspapers18. Inclusion criteria were OA of
hip or knee according to the clinical criteria of the American College
of Rheumatology19,20. Exclusion criteria were: other pathology
explaining the complaints; complaints in less than 10 out of 30
days; treatment for these complaints with exercise therapy in thepreceding 6 months; under 50 or over 80 years of age; indication
for hip or knee replacement within 1 year; contraindication for
exercise; inability to understand the Dutch language; and a low
level of limitations in activities, deﬁned as: a score< 2 on the
sections walking ability and physical function of the Algofunctional
index21,22. All patients completed written informed consent.Randomization
To avoid contamination of interventions, cluster randomization
was performed at the level of the participating physiotherapy
practices. The participating practices were randomly assigned to
one of the two treatment groups bymeans of a computer generated
random sequence table. Allocation was concealed.Interventions
BGA
BGA is a behavioral treatment integrating the concepts of
operant conditioning with exercise therapy comprising booster
sessions. BGA was based on the time-contingency management as
described by Fordyce23 and applied by Lindström24. In this indi-
vidually tailored treatment patients’ most problematic activities
were gradually increased in a time-contingent way. Furthermore,
the intervention included individually tailored exercises to improve
impairments limiting the performance of these activities. The
treatment consisted of a 12-week period with a maximum of 18
sessions, followed by ﬁve pre-set booster moments with
a maximum of seven sessions (respectively in week 18, 25, 34, 42,
and 55). After the 12-week treatment period physiotherapists
advised patients to maintain exercising and performing the activ-
ities at home. The additional booster sessions consisted of evalu-
ating, motivating (stimulating exercise adherence) and repeating
the main treatment message.
UC
The physical therapists in the UC group were requested to treat
the patients according to the Dutch physical therapy guideline for
patients with hip and/or knee OA25. This guideline consists of
general recommendations, emphasizing provision of information
and advice, exercise therapy, and encouragement of a positive
coping with the complaints. Furthermore, it is recommended to
advise patients to maintain exercising at home after discharge. The
treatment consisted of amaximum of 18 sessions within a period of
12 weeks.
More speciﬁc information on the interventions has been pub-
lished elsewhere16,17. Both BGA and UC were given individually by
physical therapists in primary care. To avoid contamination of
interventions, participating practices were randomly assigned to
one of the two treatment groups bymeans of a computer generated
random sequence table. Physical therapists in both treatment
groups received a training on the allocated treatment.Outcome measures
Demographics and clinical data
Demographic and clinical data were collected for each patient
including age, gender, height, weight, location of complaints, and
duration of complaints. X-rays of the hip and/or knee were scored
by a rheumatologist following a standardized procedure according
to the Kellgren and Lawrence (K&L) scale; consisting of ﬁve
degrees: 0, no OA; 1, doubtful OA; 2, minimal OA; 3, moderate OA
and; 4, severe OA26,27.
Table I
Baseline characteristics of both intervention groups
Characteristics BGA (n¼ 97) UC (n¼ 103)
Female, n (%) 73 (75) 81 (79)
Age, mean (sd) 65.1 (7.4) 64.5 (8.3)
Location of OA, n (%)
Knee 67 (69) 63 (61)
Hip 22 (23) 28 (27)
Both 8 (8) 12 (12)
Duration of complaints, n (%)
<1 year 23 (24) 24 (23)
1e5 years 39 (41) 33 (32)
>5 years 33 (35) 46 (45)
Radiological evidence OA (K&L 2)
Knee, n (%) 26 (52) 31 (61)
Hip, n (%) 18 (86) 29 (97)
Body mass index, mean (sd) 28.2 (4.2) 28.8 (4.6)
Signiﬁcant difference between-groups (P< 0.05).
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Pain in the last 48 h and physical functionwas assessed with the
WOMACquestionnaire28,29. PGAwasassessedbypatients onaeight-
point scale (1¼ vastly worsened; 8¼ completely recovered)30.
Secondary outcome measures
Patient-oriented physical functioning was assessed with the
MACTAR Questionnaire31. This functional indexmeasures change in
impaired activities selected by each patient in a baseline interview
(patients’ priority). Physical performance was measured with the
5 m walking test. Patients’ health care utilization for complaints
related to OA of the hip and/or knee was assessed, by asking if
patients visited health care professionals (general practitioner,
medical specialist, physical therapist, occupational therapist or
complementary/alternative therapist) in the period from discharge
to 60 months’ follow-up. Furthermore, patients were asked if they
underwent a joint replacement surgery during the study period. If
so, the operated joint and operation date were registered.
All primary and secondary outcome measures were obtained at
baseline, 3, 9, 15 and 60 months’ follow-up, with the exception of
physical performance which was not obtained at 9 months’ follow-
up. All assessments were performed on a test location, in the
presence of a research assistant, who was blinded for the assigned
treatment. The exception was the assessment at 9 months’ follow-
up, consisting of only questionnaires, which were sent by mail.
Patients were repeatedly instructed not to give information about
the allocated treatment to the research assistants. The research
assistants were asked to guess the assigned treatment immediately
after the measurements at 3, 15 and 60 months’ follow-up.
Statistical analyses
The target sample size was 200 patients. This number yields to
a power of 80% to detect a 25% difference in PGA and small to
medium-sized effects (effect-size¼ 0.2e0.4) in the outcome
measures pain and physical functioning, at two-sided signiﬁcance
level of 0.05 given a maximum loss to follow-up of 20%32.
The analyses were performed using SPSS 14.0. Descriptive
statistics were used to describe themain characteristics of the study
population and to explore baseline comparability. The statistical
analyses were carried out according to the intention-to-treat prin-
ciple. Change scores were calculated by subtracting the baseline
scores from the post-treatment scores (3, 9, 15 and 60 months,
respectively) and were compared for the two intervention groups
using Student’s t-test. The ratings of PGA were dichotomized as
improved (“completely recovered”, “very much improved” and
“much improved”) vs not improved (“slightly improved”, “not
changed”, “slightly worsened”, “much worsened” and “vastly
worsened”). Odds ratios (ORs) with their 95% conﬁdence intervals
(CIs) were calculated to test differences between intervention
groups. In order to adjust for differences in patients’ condition,
multiple linear or logistic regression analyses were performed with
the change scores as dependent variable and type of intervention as
independent variable. The following characteristics were used as
covariates in the adjusted analyses: the baseline scores of each
outcomemeasure, duration of symptoms, location of OA (hip, knee,
or both), age, sex, and recruitment method (physical therapist or
newspaper). To investigate the risk for joint replacement surgery
Cox-proportional hazard statistics were used with time at risk in
months as underlying time variable. Hazard ratios (HRs) and 95% CIs
were calculated to test the difference between treatment groups.
Using KaplaneMeier plots the risk for joint replacement surgery
over the 5 years follow-up period for each treatmentwas illustrated.
In all analyses P values less than 0.05 were considered statistically
signiﬁcant. In addition, all analyses were also performed ona multi-level basis (using MLwiN) to correct for dependency of
observations within subjects and taking into account variation
between physiotherapists33,34. Furthermore, an exploratory per-
protocol analysis (not preplanned in research protocol) was per-
formed in which patients who underwent a joint replacement
surgery during the study were considered as lost to follow-up from
operation date.Results
A total of 200 patients were included in the trial: 97 patients in
the BGA group and 103 patients in the UC group. The BGA group and
UC group had similar baseline characteristics and baseline values of
outcome measures, as presented in Table I. The 60 months’ follow-
up (5 years after inclusion) assessment was completed by 76 BGA
patients and 73 UC patients. A non-response analysis was per-
formed in which the baseline characteristics of patients who were
lost to follow-up were compared with characteristics of patients
assessed at 60 months’ follow-up. No statistical signiﬁcant differ-
ences were found. Fifty-ﬁve physical therapists treated the patients
included in this study. Information about the patient ﬂow through
the trial is presented in Fig.1. One patient of the BGA group reported
adverse effects (increase of pain) and withdrew at the end of the
therapy (after three booster sessions). At 60 months’ follow-up 35%
UC patients and 28% BGA patients were still adherent to the rec-
ommended home exercises (OR¼ 0.69 [0.3; 1.4]).
In the long-term (60 months’ follow-up), patients in both treat-
ment groups improved on all primary outcome measures. The
differences between treatment groups in pain (0.18 [1.7; 1.4]),
physical function (1.92 [6.5; 2.6]) and PGA (OR¼ 0.67 [0.3; 1.4])
were small and not statistically signiﬁcant. Similar results were
found on most secondary outcome measures at 60 months’ follow-
up, namely patient-oriented physical functioning, physical perfor-
manceandhealthcareutilizationafterdischarge. Theonlysigniﬁcant
difference between treatment groups was found in the number of
patients that underwent a joint replacement surgery during the
studyperiod.Namely, in theBGA treatment group14patients (14.4%)
underwent a joint replacement surgery during the study period
compared to 25 patients (24.3%) in the UC treatment group. Cox-
proportional hazard analysis showed that the risk for joint replace-
ment surgery was signiﬁcantly higher for patients treated with UC
compared to BGA (HR [95% CI]¼ 2.10 [1.1; 4.1]). As indicated by
a signiﬁcant interaction term, the location of OA (hip, knee or both)
was a modiﬁer of the relationship between treatment group and the
risk for joint replacement surgery. Although itwas not preplanned in
our researchprotocol, the data on the long-termeffectiveness of BGA
Assessed for eligibility (n=341)
Patient recruited by physical therapists (n =136) 
Patients admitted through newspaper (n =205) 
Excluded (n=141) 
Did not meet inclusion criteria (n=77) 
Negative advice GP (n=17) 
Not motivated (n=42) 
Reason unknown (n=5) 
Randomized (n=200) 
Allocated to Behavioral Graded Activity (n=97) 
Received allocated treatment (n=93) 
    Deviation from treatment protocol (n=21) 
Did not receive allocated intervention: 
Co morbidity (n=3) 
   Family circumstances (n=1)
Allocated to Usual Care (n=103) 
Received allocated treatment (n=102) 
    Deviation from treatment protocol (n=16) 
Did not receive allocated intervention:   
    Declined to participate (n=1) 
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Physical therapists (n=26) 
Centers performing the intervention (n=23) 
Number of patients treated by each care provider 
    IQR = 4 
    Max.=12 
    Min.=1 
Physical therapists (n=29) 
Centers performing the intervention (n=23) 
Number of patients treated by each care provider 
    IQR = 4 
    Max.=10 
   Min.=1
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Follow-up 3 months (n=90) 
Lost to follow-up (n=7) 
Co morbidity (n=3) 
    THR/TKR (n=3; only lost to follow-up week 13) 
    Family circumstances (n=1) 
Follow-up 3 months (n=102) 
Lost to follow-up (n=1) 
Declined to participate (n=1) 
Follow-up 15 months (n=87) 
Lost to follow-up (n= 6) 
Co morbidity (n=2) 
    No motivation (n=2) 
    Increased pain (n=1) 
    Movement (n=1)
Follow-up 15 months (n=92) 
Lost to follow-up (n=5) 
    No motivation (n=2) 
    Co morbidity (n=1) 
    Family circumstances (n=1) 
  Lost contact (n=1))
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Follow-up 5 yr (n=76) 
Lost to follow-up (n= 11) 
No motivation (n=5)
    Movement (n=4) 
   Co morbidity (n=1) 
   Deceased (n=1)
Follow-up 5yr (n=73) 
Lost to follow-up (n=19) 
No motivation (n=6) 
    Movement (n=6)
    Co morbidity (n=5) 
   Deceased (n=2)
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Follow-up 9 months (n=82) 
Lost to follow-up (n=11)  
Only at 9 months lost to follow-up (n=11) 
Follow-up 9 months (n=88) 
Lost to follow-up (n=14) 
Cost intervention (n=1)) 
    No motivation (n=4)) 
   Only at 9 months lost to follow-up (n=9) 
Fig. 1. Flow diagram through study.
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patients with knee OA, since the location of OA was found to be
a signiﬁcant interaction term.BecauseVeenhofet al.16 onlypresented
the results for the total group of patients with OA (after 3, 9, and 15
months’ follow-up), we also include the results on the short- and
mid-long-term for patients with hip and knee OA separately.
Patients with hip OA
In total 70 patients with hip OA were included in the trial:
30 patients in the BGA group and 40 patients in the UC group.In the long-term (60 months’ follow-up) no signiﬁcant differ-
ences were found between treatment groups on the primary and
most secondary outcomes (patient-oriented physical function
and physical performance), see Table II. However, in the BGA
treatment group only six patients with hip OA (20.0%) under-
went a joint replacement surgery during the study period
compared to 18 patients with hip OA (45.0%) in the UC treat-
ment group. Cox-proportional hazard analysis showed that the
risk for joint replacement surgery was signiﬁcantly higher for
patients treated with UC compared to BGA (HR¼ 2.87 [1.1; 7.3]),
see Fig. 2.
Table II
Outcome in intervention groups in patients with hip OA (n¼ 70)
Outcome measures BGA UC Difference BGA UC [95% CI] Adjusted difference [95% CI]y
n Mean [95% CI] n Mean [95% CI]
Pain, subscale WOMAC: 0e20
Baseline, mean (sd) 30 9.9 (2.3) 40 8.4 (2.9)
D 3 Months baseline 26 2.57 [3.6; 1.6] 40 1.10 [2.0; 0.2] 1.46 [2.8; 0.1]* 1.02 [2.3; 0.3]
D 9 Months e baseline 26 3.12 [4.8; 1.4] 36 0.06 [1.2; 1.1] 3.05 [4.9; 1.2]* 2.47 [4.4; 0.5]*
D 15 Months baseline 25 3.88 [5.4; 2.3] 35 2.54 [3.6;1.5] 1.34 [3.1; 0.4] 0.13 [1.9; 1.7]
D 60 Months baseline 20 4.70 [6.6; 2.8] 31 3.59 [5.3; 1.9] 1.10 [3.6; 1.4] 0.33 [3.1; 2.4]
Physical function, subscale WOMAC: 0e68
Baseline, mean (sd) 30 29.47 (11.3) 40 29.10 (8.5)
D 3 Months baseline 25 4.55 [8.0; 1.1] 40 3.28 [5.6;0.9] 1.25 [5.1; 2.7] 0.61 [4.7; 3.5]
D 9 Months baseline 24 6.81 [11.0; 2.6] 34 1.64 [4.4; 1.2] 5.15 [9.9; 0.4]* 4.10 [9.0; 0.8]
D 15 Months baseline 24 6.99 [12.5; 1.5] 35 5.23 [8.8;1.7] 1.75 [7.8; 4.3] 0.45 [5.2; 6.1]
D 60 Months baseline 21 13.34 [19.2; 7.5] 31 10.06 [15.3; 4.9] 3.26 [11.0; 4.4] 2.13 [9.4; 5.2]
PGA OR OR
3 Months, % (n) improved 26 35 (9) 40 23 (9) 1.94 [0.6; 5.8] 1.41 [0.4; 4.7]
9 Months, % (n) improved 25 52 (13) 36 14 (5) 6.72 [2.0; 22.9]* 5.98 [1.6; 22.0]*
15 Months, % (n) improved 24 58 (14) 32 36 (12) 2.45 [0.8; 7.2] 1.61 [0.5; 5.5]
60 Months, % (n) improved 21 57 (12) 28 50 (14) 1.33 [0.4; 4.2] 0.71 [0.2; 2.9]
Patient-oriented physical function, MACTAR: 15 to 15
D 3 Months baseline 26 6.62 [4.5; 8.8] 40 4.55 [2.3; 6.8] 2.04 [1.1; 5.2] 1.44 [1.9; 4.8]
D 9 Months baseline 28 6.96 [3.8; 10.1] 38 0.97 [3.6; 1.7] 7.93 [3.9; 11.9]* 7.26 [3.1; 11.4]*
D 15 Months baseline 25 5.60 [2.3; 8.9] 35 1.54 [1.4; 4.5] 4.05 [0.3; 8.4] 3.69 [1.1; 8.5]
D 60 Months baseline 20 5.55 [1.4; 9.7] 31 5.32 [1.8; 8.8] 0.23 [5.1; 5.5] 0.15 [5.1; 5.4]
Physical performance, 5 m walking in s
Baseline, mean (sd) 28 4.9 (1.3) 40 4.5 (0.9)
D 3 Months baseline 25 0.56 [1.0; 0.1] 39 0.11 [0.2; 0.4] 0.65 [1.1; 0.2]* 0.46 [0.9; 0.1]*
D 15 Months baseline 20 0.71 [1.4; 0.1] 32 0.04 [0.3; 0.3] 0.66 [1.3; 0.1]* 0.41 [0.8; 0.0]*
D 60 Months baseline 19 0.42 [1.1; 0.2] 28 0.20 [0.3; 0.7] 0.63 [1.4; 0.2] 0.37 [1.0; 0.3]
Negative signs indicate improvement within-groups or improvement in favor of BGA (in case of differences in change between-groups), with the exception of MACTAR.
Concerning PGA OR> 1 indicates improvement in favor of BGA.
* P< 0.05.
y Analysis are adjusted for the baseline score of each outcome measure, duration of complaints, age, sex, and recruitment method (physiotherapist or newspaper).
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on the short-term (3 months’ follow-up) and mid-long-term (9 and
15 months’ follow-up) for patients with hip OA. At the short-term
the differences between treatment groups were mostly not statis-
tically signiﬁcant. Only on pain and physical performance a signiﬁ-
cant difference in favor of BGAwas found. However, the differences
between treatment groups in favor of BGA increased at the mid-
long-term (9 months’ follow-up) and were statistically signiﬁcant
for pain, physical function, PGA and patient-oriented physical
function. At 15 and 60 months no signiﬁcant differences between
treatment groups were found (see Table II). Only on physical
performance a signiﬁcant difference between treatment groups in
favor of BGA was found at 15 months’ follow-up.0.
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Fig. 2. KaplaneMeier survival curve for patients with hip OA.Patients with knee OA
Table III presents the results for patients with knee OA on the
primary outcome measures. In total 150 patients with knee OA
were included in the trial: 75 patients in the BGA group and 75
patients in the UC group. Although the results were mostly in favor
of BGA, the differences between treatment groups on the primary
and secondary outcome measures were small and not statistically
signiﬁcant, as well at the short-term, mid-long-term and long-
term. Also no differences were found in the risk for joint replace-
ment surgery between treatment groups in patients with knee OA
(HR [95% CI]¼ 1.11 [0.4; 2.8]). In both treatment groups nine
patients with knee OA (12.0%) underwent a joint replacement
surgery during the study period.
Blinding
The research assistants were asked to guess the assigned treat-
ment immediately after the measurements at 3, 15 and 60 months’
follow-up. The research assistants guessed the assigned treatment
in 57% of the cases at 3 months’ follow-up (Cohen’s kappa¼ 0.14),
46% of the cases at 15 months’ follow-up (Cohen’s kappa¼0.09),
and51%of the cases at 60months’ follow-up (Cohen’s kappa¼ 0.03).
Additional analyses
In order to correct for dependency of observations within
subjects and taking into account variation between physiothera-
pists all analyses were additionally also performed on a multi-level
basis (level: time, patient, and physical therapist). The multi-level
analysis yielded similar results (data not presented). To investigate
Table III
Outcome in intervention groups in patients with knee OA (n¼ 150)
Outcome measures BGA UC Difference BGAUC [95% CI] Adjusted difference [95% CI] *
n Mean [95% CI] n Mean [95% CI]
Pain, subscale WOMAC: 0e20
Baseline, mean (sd) 75 9.0 (3.6) 75 8.7 (3.2)
D 3 Months baseline 69 2.22 [3.0; 1.5] 74 2.47 [3.3; 1.7] 0.25 [0.9; 1.4] 0.42 [0.6; 1.4]
D 9 Months baseline 61 1.80 [2.9;0.7] 62 1.23 [2.3; 0.2] 0.57 [2.1; 1.0] 0.32 [1.8; 1.1]
D 15 Months baseline 66 3.86 [4.9;2.9] 66 3.39 [4.2;2.6] 0.47 [1.7; 0.8] 0.23 [1.3; 0.9]
D 60 Months baseline 55 2.27 [3.7; 0.9] 47 1.63 [2.8; 0.5] 0.63 [2.5; 1.2] 0.55 [2.3; 1.2]
Physical function, subscale, WOMAC: 0e68
Baseline, mean (sd) 70 28.9 (13.2) 75 28.7 (10.7)
D 3 Months baseline 63 6.30 [8.6; 4.0] 74 5.99 [8.2; 3.8] 0.30 [3.4; 2.8] 0.26 [3.2; 2.6]
D 9 Months baseline 60 6.36 [9.5; 3.2] 60 6.45 [9.2; 3.7] 0.10 [4.0; 4.2] 0.37 [3.5; 4.2]
D 15 Months baseline 60 7.21 [10.9; 3.6] 63 8.23 [10.5; 5.9] 1.02 [3.2; 5.2] 1.38 [2.3; 5.0]
D 60 Months baseline 51 8.54 [12.8; 4.3] 45 5.53 [9.0; 2.0] 3.01 [8.5; 2.5] 2.87 [7.7; 2.0]
PGA OR OR
3 Months, % (n) improved 69 41 (28) 74 39 (29) 1.10 [0.6; 2.2] 1.20 [0.6; 2.4]
9 Months, % (n) improved 59 34 (20) 60 32 (19) 1.05 [0.5; 2.3] 1.16 [0.5; 2.6]
15 Months, % (n) improved 67 52 (35) 63 51 (32) 1.03 [0.5; 2.1] 1.01 [0.5; 2.1]
60 Months, % (n) improved 55 49 (27) 46 35 (16) 1.74 [0.8; 3.9] 1.78 [0.8; 4.1]
Physical function, MACTAR: 15 to 15
D 3 Months baseline 69 6.09 [4.7; 7.5] 74 5.30 [3.7; 6.9] 0.79 [1.3; 2.9] 0.89 [1.2; 3.0]
D 9 Months baseline 72 3.24 [1.2; 5.2] 70 3.33 [1.4; 5.2] 0.09 [2.8; 2.7] 0.05 [2.8; 2.7]
D 15 Months baseline 67 6.18 [4.4; 8.0] 66 4.00 [2.3; 5.7] 2.18 [0.3; 4.7] 2.25 [0.2; 4.7]
D 60 Months baseline 54 3.59 [1.0; 6.2] 46 1.70 [1.1; 4.5] 1.89 [1.8; 5.6] 2.05 [1.6; 5.7]
Physical function, 5 m walking in s
Baseline, mean (sd) 73 4.8 (1.2) 75 4.9 (1.6)
D 3 Months baseline 68 0.32 [0.5; 0.1] 73 0.31 [0.5; 0.1] 0.01 [0.3; 0.3] 0.05 [0.3; 0.2]
D 15 Months baseline 61 0.32 [0.6; 0.1] 64 0.15 [0.4; 0.1] 0.17 [0.5; 0.2] 0.23 [0.5; 0.0]
D 60 Months baseline 51 0.16 [0.2; 0.5] 43 0.34 [0.0; 0.6] 0.18 [0.7; 0.3] 0.21 [0.6; 0.2]
Negative signs indicate improvement within-groups or improvement in favor of BGA (in case of differences in change between-groups), with the exception of MACTAR.
Concerning PGA OR> 1 indicates improvement in favor of BGA.
* Analyses are adjusted for the baseline score of each outcome measure, duration of complaints, age, sex, and recruitment method (physiotherapist or newspaper).
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and long-term on primary and secondary outcome measures were
biased by the difference in the number of joint replacement
surgeries between treatments a exploratory per-protocol analysis
(not preplanned in research protocol) was performed. In this per-
protocol analysis all patients who underwent a joint replacement
surgery during the study period were considered as lost to follow-
up from operation date. The differences between treatment groups
in patients with hip OA increased considerably in favor of BGA on all
outcome measures at 15 months’ and 60 months’ follow-up. For
instance, the differences between treatment groups on physical
function in patients with hip OA at 15 and 60 months’ follow-up
increased respectively from1.75 [7.8; 4.3] and3.26 [11.0; 4.4]
(patients with arthroplasty included) to 3.67 [9.8; 2.4] and
7.92 [17.7; 1.9] (patients with arthroplasty considered as lost to
follow-up from operation date) (see Fig. 3). However, these differ-
ences were not statistically signiﬁcant. In patients with knee OA the
per-protocol analysis yielded similar results compared to the
intention-to-treat analyses.-16
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Fig. 3. Change in physical function (WOMAC) in patients with hip OA. Negative signs
indicate improvement differences between intention-to-treat and per-protocol anal-
ysis (all patients who underwent a joint replacement surgery during the study period
were considered lost to follow-up from operation date).Discussion
This follow-up study was designed to evaluate whether a BGA
results in better long-term effectiveness than UC in patients with
OA of the hip and/or knee. Both treatment groups showed beneﬁ-
cial effects in the long-term. No signiﬁcant differences between
treatment groups were found on the primary outcome measures at
5 years follow-up, as well in patients with hip OA as in patients with
knee OA. However, in patients with hip OA BGA resulted in the
long-term in less joint replacement surgeries than UC.
In the literature it is often suggested that lowexercise adherence
rates and a lack of regular physical activity post-treatment areimportant reasons for poor long-term effectiveness of exercise
therapy12,13. Since BGA results in better exercise adherence and
amore physically active lifestyle in the short- andmid-long-term26,
the hypothesis was that BGA would result in better long-term
effectiveness than UC. Surprisingly, both BGA and UC resulted in
beneﬁcial within-groups effects on pain and physical function in
the long-term (5 years after inclusion). No signiﬁcant differences
were found between treatment groups. It was expected that UC
would only result in short-term effects, because several studies
have demonstrated that the beneﬁcial effect of exercise therapy in
patients with OA declines after discharge and ﬁnally disappears in
the mid-long-term11,35. In patients with hip OA it is likely that the
results of UC on pain and physical function at 15 and 60 months’
follow-up were biased by patients who underwent joint
M.F. Pisters et al. / Osteoarthritis and Cartilage 18 (2010) 1019e1026 1025replacement surgery during the study period. This was conﬁrmed
in exploratory per-protocol analysis, in which patients who
underwent a joint replacement surgery during the study period
were considered as lost to follow-up from operation date. Namely,
the exploratory per-protocol analysis demonstrated that the
differences increased considerably in favor of BGA on all outcome
measures, due to a decline in effectiveness in patients treated with
UC in the mid-long-term and long-term. However, these differ-
ences between treatment groups at 15 and 60 months’ follow-up
were not statistically signiﬁcant, which is probably due to a lack of
power.
The reduced risk for joint replacement surgery in BGA patients
with hip OAmay be due to the beneﬁcial effects of BGA in the short-
term and mid-long-term on pain and physical function. In the
short-term (3 months’ follow-up) a signiﬁcant difference in favor of
BGA was found on pain and physical performance in patients with
hip OA. In the mid-long-term (9 months’ follow-up) on almost all
outcome measures a signiﬁcant difference was found in favor of
BGA in patients with hip OA, namely pain, physical function, PGA,
and patient-oriented physical function. Apparently, the beneﬁcial
effects of BGA in the short- and mid-long-term are large enough to
postpone joint replacement surgery. Comparable results were
found in patients with knee OA by Deyle et al., in which was
demonstrated that a combination of manual physical therapy and
supervised exercise yields functional beneﬁts and may delay or
prevent the need for surgical intervention36. However, since our
study was not speciﬁcally designed to investigate the effect of
exercise therapy on the risk for joint replacement surgery and the
possibility exists that the found difference in the risk for joint
replacement surgery was due to a type-1 error (false positive
outcome), further research to conﬁrm our ﬁndings is needed.
Several studies in which the effectiveness of exercise therapy in
patients with OA was investigated found similar results for patients
with hip OA and patients with knee OA35,37. Surprisingly, the results
of our study showed differently. In patients with hip OA the results
were in favor of BGA and in patients with knee OA both treatments
were equally effective. A possible explanation could be that the
biomechanical, psychological or clinical prognostic or risk factors for
functional decline are different for patients with hip and knee OA.
Because existing studiesonprognostic or risk factorsaremainlydone
in patients with knee OA38, this possibility cannot be fully evaluated.
Themain goal of exercise therapy is to eliminate potential risk factors
for functional decline and improve overall physical function, so that
individuals canmeet as longaspossible thedemandsofdaily living39.
Due to the positive results in favor of BGA in patients with hip OA, it
can be concluded that integratingmore functional and task-oriented
exercises and strategies directed at behavioral change are in partic-
ularly important for patients with hip OA.
There are a few limitations to this study that need to be
mentioned. First of all, the lost to follow-up rate at 5 years’ follow-
up (26%) was higher than expected (20%). The sample of 149
patients which were followed until 5 years’ follow-up was smaller
than the sample size required by our power analysis. To detect
a small to medium effect-size (0.2e0.4) in the outcome measures
pain and physical functioning (with a two-sided signiﬁcance level
of 0.05 and power of 80%) in the long-term, the sample size needed
to be at least 80 per group. The power calculation was done based
on the assumption that both treatments would show similar results
in patients with knee and hip OA. Surprisingly, the location of OA
seemed to be a modiﬁer of the relationship between the allocated
treatment and outcome. For this reason the data needed to be
analyzed separately for patients with knee OA and patients with
hip OA. Consequently, our studywas theoretically underpowered to
detect any between-group differences. However, although there
was a lack of power, signiﬁcant and clinically relevant effects werefound in patients with hip OA. Secondly, results of our study could
be biased by the number of patients which were lost to follow-up,
which was 26% at the long-term follow-up (5 years after inclusion).
However, the non-response analysis showed similar baseline
characteristics for responders and non-responders.
In conclusion, both treatment groups show beneﬁcial within-
groups results in the long-term. No signiﬁcant differences between
treatment groups were found in the long-term on pain, physical
function and PGA, both in patients with knee and hip OA. Although
more research is needed to conﬁrm the study ﬁndings, the results
indicate that BGA reduces the risk for joint replacement surgeries
compared to UC in patients with hip OA, which probably can be
explained by better outcome in favor of BGA in the short- and mid-
long-term.
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